199 related articles for article (PubMed ID: 26608329)
21. Fibrinogen naples I (B beta A68T) nonsubstrate thrombin-binding capacities.
Meh DA; Mosesson MW; Siebenlist KR; Simpson-Haidaris PJ; Brennan SO; DiOrio JP; Thompson K; Di Minno G
Thromb Res; 2001 Jul; 103(1):63-73. PubMed ID: 11434947
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of clot density, fibrin fiber radius, and protofibril packing in acute phase myocardial infarction.
Siniarski A; Baker SR; Duval C; Malinowski KP; Gajos G; Nessler J; Ariëns RAS
Thromb Res; 2021 Sep; 205():110-119. PubMed ID: 34298252
[TBL] [Abstract][Full Text] [Related]
23. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation.
Mosesson MW
Thromb Haemost; 2003 Jan; 89(1):9-12. PubMed ID: 12540947
[TBL] [Abstract][Full Text] [Related]
24. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
Zhu S; Chen J; Diamond SL
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
[TBL] [Abstract][Full Text] [Related]
25. Mathematical modeling to understand the role of bivalent thrombin-fibrin binding during polymerization.
Kelley MA; Leiderman K
PLoS Comput Biol; 2022 Sep; 18(9):e1010414. PubMed ID: 36107837
[TBL] [Abstract][Full Text] [Related]
26. CVD risk factors are related to plasma fibrin clot properties independent of total and or γ' fibrinogen concentration.
Kotzé RC; Ariëns RA; de Lange Z; Pieters M
Thromb Res; 2014 Nov; 134(5):963-9. PubMed ID: 25213709
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ'.
Omarova F; Uitte De Willige S; Ariëns RA; Rosing J; Bertina RM; Castoldi E
J Thromb Haemost; 2013 Sep; 11(9):1669-78. PubMed ID: 23848367
[TBL] [Abstract][Full Text] [Related]
28. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.
Collet JP; Nagaswami C; Farrell DH; Montalescot G; Weisel JW
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):382-6. PubMed ID: 14656741
[TBL] [Abstract][Full Text] [Related]
29. Does topology drive fiber polymerization?
Huang L; Hsiao JP; Powierza C; Taylor RM; Lord ST
Biochemistry; 2014 Dec; 53(49):7824-34. PubMed ID: 25419972
[TBL] [Abstract][Full Text] [Related]
30. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
Mullin JL; Gorkun OV; Lord ST
Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
[TBL] [Abstract][Full Text] [Related]
31. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
[TBL] [Abstract][Full Text] [Related]
32. Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.
Siebenlist KR; Mosesson MW; Hernandez I; Bush LA; Di Cera E; Shainoff JR; Di Orio JP; Stojanovic L
Blood; 2005 Oct; 106(8):2730-6. PubMed ID: 16002430
[TBL] [Abstract][Full Text] [Related]
33. Fibrin clot formation under diverse clotting conditions: Comparing turbidimetry and thromboelastography.
Zeng Z; Fagnon M; Nallan Chakravarthula T; Alves NJ
Thromb Res; 2020 Mar; 187():48-55. PubMed ID: 31954276
[TBL] [Abstract][Full Text] [Related]
34. Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain.
Alexander KS; Fried MG; Farrell DH
Biochemistry; 2012 Apr; 51(16):3445-50. PubMed ID: 22439748
[TBL] [Abstract][Full Text] [Related]
35. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
[TBL] [Abstract][Full Text] [Related]
36. Fibrin protofibril packing and clot stability are enhanced by extended knob-hole interactions and catch-slip bonds.
Asquith NL; Duval C; Zhmurov A; Baker SR; McPherson HR; Domingues MM; Connell SDA; Barsegov V; Ariëns RAS
Blood Adv; 2022 Jul; 6(13):4015-4027. PubMed ID: 35561308
[TBL] [Abstract][Full Text] [Related]
37. Fibrinogen splice variation and cross-linking: Effects on fibrin structure/function and role of fibrinogen γ' as thrombomobulin II.
Duval C; Ariëns RAS
Matrix Biol; 2017 Jul; 60-61():8-15. PubMed ID: 27784620
[TBL] [Abstract][Full Text] [Related]
38. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
Falls LA; Farrell DH
J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
[TBL] [Abstract][Full Text] [Related]
39. Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.
Kim PY; Vu TT; Leslie BA; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2014 Oct; 289(40):27494-503. PubMed ID: 25128532
[TBL] [Abstract][Full Text] [Related]
40. Update on antithrombin I (fibrin).
Mosesson MW
Thromb Haemost; 2007 Jul; 98(1):105-8. PubMed ID: 17597999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
